(Q40199219)

18 September 2017

Treatment of heart failure by calcium cycling gene therapy (English)

1 reference

18 September 2017

0 references

1

Larissa Lipskaia

1 reference

18 September 2017

Hung Ly

2

1 reference

18 September 2017

Yoshiaki Kawase

series ordinal

3

1 reference

18 September 2017

Roger J Hajjar

series ordinal

4

1 reference

18 September 2017

Anne-Marie Lompre

series ordinal

5

1 reference

18 September 2017

1 July 2007

1 reference

18 September 2017

1 reference

18 September 2017

3

1 reference

18 September 2017

4

1 reference

18 September 2017

413-423

1 reference

Type 1 phosphatase, a negative regulator of cardiac function

18 September 2017

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

PKC-alpha regulates cardiac contractility and propensity toward heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Mechanisms of disease: beta-adrenergic receptors--alterations in signal transduction and pharmacogenomics in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Altered sarcoplasmic reticulum Ca2(+)-ATPase gene expression in the human ventricle during end-stage heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Phospholamban: a crucial regulator of cardiac contractility

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Regulation of cardiac hypertrophy by intracellular signalling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Targeted disruption of NFATc3, but not NFATc4, reveals an intrinsic defect in calcineurin-mediated cardiac hypertrophic growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Direct interaction and reciprocal regulation between ASK1 and calcineurin-NFAT control cardiomyocyte death and growth

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Lipopolysaccharide activates calcineurin in ventricular myocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

TRPC6 fulfills a calcineurin signaling circuit during pathologic cardiac remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Calcineurin-dependent cardiomyopathy is activated by TRPC in the adult mouse heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Calcineurin-GATA4 pathway is involved in beta-adrenergic agonist-responsive endothelin-1 transcription in cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

cAMP-binding protein Epac induces cardiomyocyte hypertrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Local InsP3-dependent perinuclear Ca2+ signaling in cardiac myocyte excitation-transcription coupling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

What is the role of beta-adrenergic signaling in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Beta-adrenergic axis and heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Dual modulation of cell survival and cell death by beta(2)-adrenergic signaling in adult mouse cardiac myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Subtype-specific alpha1- and beta-adrenoceptor signaling in the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Adenylyl cyclase: a new target for heart failure therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Enhanced cardiac function in transgenic mice expressing a Ca(2+)-stimulated adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Cyclic AMP compartmentation due to increased cAMP-phosphodiesterase activity in transgenic mice with a cardiac-directed expression of the human adenylyl cyclase type 8 (AC8).

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Intracoronary adenovirus encoding adenylyl cyclase VI increases left ventricular function in heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Adenylylcyclase gene transfer increases function of the failing heart.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Altered beta-adrenergic receptor gene regulation and signaling in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Targeting phospholamban by gene transfer in human heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Dilated cardiomyopathy and heart failure caused by a mutation in phospholamban

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Targeting calcium cycling proteins in heart failure through gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

SERCA2A overexpression decreases the incidence of aftercontractions in adult rabbit ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Overexpression of the sarcoplasmic reticulum Ca(2+)-ATPase improves myocardial contractility in diabetic cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Transgenic expression of sarcoplasmic reticulum Ca(2+) atpase modifies the transition from hypertrophy to early heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Transgenic rat hearts overexpressing SERCA2a show improved contractility under baseline conditions and pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Improvement in survival and cardiac metabolism after gene transfer of sarcoplasmic reticulum Ca(2+)-ATPase in a rat model of heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Abrogation of ventricular arrhythmias in a model of ischemia and reperfusion by targeting myocardial calcium cycling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Sarco/endoplasmic reticulum Ca2+-ATPase gene transfer reduces vascular smooth muscle cell proliferation and neointima formation in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Decreased efficiency of adenovirus-mediated gene transfer in aging cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Effects of adeno-associated virus DNA hairpin structure on recombination

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Adeno-associated virus serotypes: vector toolkit for human gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Systemic delivery of genes to striated muscles using adeno-associated viral vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8.

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Recombinant adeno-associated virus serotype 9 leads to preferential cardiac transduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Adeno-associated virus serotype 8 efficiently delivers genes to muscle and heart

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Self-complementary adeno-associated virus serotype 2 vector: global distribution and broad dispersion of AAV-mediated transgene expression in mouse brain

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Adeno-associated virus terminal repeat (TR) mutant generates self-complementary vectors to overcome the rate-limiting step to transduction in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Vigilant vector: heart-specific promoter in an adeno-associated virus vector for cardioprotection

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Growth factor-induced therapeutic angiogenesis and arteriogenesis in the heart--gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Modulation of ventricular function through gene transfer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

New efficient catheter-based system for myocardial gene delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Phosphodiesterase inhibitor-mediated potentiation of adenovirus delivery to myocardium

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

How to optimize in vivo gene transfer to cardiac myocytes: mechanical or pharmacological procedures?

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Catheter-based antegrade intracoronary viral gene delivery with coronary venous blockade

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Assessment of risks associated with cardiovascular gene therapy in human subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Gene therapy with vascular endothelial growth factor for inoperable coronary artery disease: anesthetic management and results

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

Cyclic AMP Imaging in Adult Cardiac Myocytes Reveals Far-Reaching β 1 -Adrenergic but Locally Confined β 2 -Adrenergic Receptor–Mediated Signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.2217%2F14796678.3.4.413

21 January 2018

Identifiers

DOI

10.2217/14796678.3.4.413

1 reference

18 September 2017

1 reference